Biotech | November 12, 2025
Samsung Epis launches new biotech subsidiary Epis NexLab
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
The results demonstrated meaningful reductions in the severity of involuntary movements and notable improvements in patient-reported quality of life
The pharma giant's 11% rise in total revenue to $43.2 billion highlights consistent execution of its growth strategy
Venus Remedies now has 29 active product approvals in Vietnam alone
The FDA setback highlights ongoing tensions between patient needs, regulatory processes, and the use of real-world evidence in evaluating treatments for rare diseases
Poviztra is a second brand of Wegovy
The approval granted with zero supplementation requests is an important milestone in Glenmark’s respiratory pipeline
Sumatriptan injection is indicated in adults for the acute treatment of migraine
The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Sprycel Tablets
Subscribe To Our Newsletter & Stay Updated
